Skip to main content

Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie

  • Chapter
Weiterbildung Intensivmedizin und Notfallmedizin
  • 4511 Accesses

Zusammenfassung

„Critical illness polyneuropathy“ (CIP) und „critical illness myopathy“ (CIM) sind häufige Komplikationen einer schweren Erkrankung, insbesondere Sepsis, SIRS (systemisches inflammatorisches Response-Syndrom) und Multiorganversagen. Hauptsymptome sind die muskuläre Schwäche und Probleme bei der Entwöhnung von der Beatmung. CIP und CIM führen zu verlängerten Beatmungszeiten, längeren Aufenthalten in Klinik- und Rehabilitationseinrichtungen und zu einer erhöhten Mortalität. Elektrophysiologische Messungen können beide Entitäten relativ früh im Verlauf der Erkrankung nachweisen. Eine frühe leitliniengerechte Sepsistherapie ist das wichtigste Instrument, die Entwicklung einer CIP oder CIM zu vermeiden. Obwohl zurzeit keine spezifische Therapie für CIP und CIM bekannt ist, verbessert die Diagnose das therapeutische Management (Entwöhnung von der Beatmung, frühe Physiotherapie, etc.). Der Beitrag gibt eine Übersicht über die klinischen und diagnostischen Zeichen von CIP und CIM und umreißt aktuelle pathophysiologische und therapeutische Konzepte.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Axer H, Romeike B, Brunkhorst F et al (2011) Neurological sequelae of sepsis: II) neuromuscular weakness. Open Crit Care Med J 4:81–4

    Google Scholar 

  2. Bierbrauer J, Koch S, Olbricht C et al (2012) Early type II fiberatrophy in intensive care unit patients with no nexcitable musde membrane. Crit Care Med 40:647–650

    Article  PubMed  Google Scholar 

  3. Bolton CF, Gilbert JJ, Hahn AF et al (1984) Polyneuropathy in critically ill patients. J Neural Neurosurg Psy chiatry 47:1223–1231

    Google Scholar 

  4. Finfer S, Chittock DR, Su SYS et al (2009) Intensive versus conventio nal glucose control in critically ill patients. N Engl J Med 360:1283–1297

    PubMed  Google Scholar 

  5. Fletcher SN, Kennedy DD, Ghosh IR etal (2003) Persistent neuromuscular and neurophysiologicabnormal ities in longterm survivors of pro longed critical illness. Crit Care Med 31:1012–1016

    Article  PubMed  Google Scholar 

  6. GarnachoMontero J, AmayaVillar R, GarciaGarmendia JL et al (2005) Effect of critical illness polyneuropathy on the withdrawal from mecha nical Ventilation and the length of stay in septic patients. Crit Care Med 33:349–354

    Google Scholar 

  7. GarnachoMontero J, Madrazo Osuna J, GarciaGarmendia JL et al (2001) Critical illness polyneuropathy: risk factors and clinical conse quences. A cohort study in septic patients. Intensive Care Med 27:1288–1296

    Google Scholar 

  8. Griffiths RD, Hall JB (2010) Intensive care unitacquired weakness. Crit Care Med 38:779–787

    PubMed  Google Scholar 

  9. Guarneri B, Bertolini G, Latronico N (2008) Longterm outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neural Neurosurg Psychiatry 79:838–841

    Article  Google Scholar 

  10. HermansG, DeJongheB, Bruyninckx F et al (2008) Clinical review: Critical illness polyneuropathy and myopathy. Crit Care 12:23–8

    Google Scholar 

  11. HermansG, Vanhorebeekl, DerdeS et al (2009) Metabolie aspects of critical illness polyneuromyopathy. Crit Care Med 37:S391–397

    Google Scholar 

  12. Khan J, Harrison TB, Rieh MM etal (2006) Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurolo gy 67:1421–1425

    Google Scholar 

  13. Lacomis D, Giuliani MJ, Van Cott A et al (1996) Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neural 40:645–654

    Article  Google Scholar 

  14. Lacomis D, Zochodne DW, Bird SJ (2000) Critical illness myopathy. Muscle Nerve 23:1785–1788

    Article  PubMed  Google Scholar 

  15. Lacomis D (2011) Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis 12:197–218

    Article  PubMed  Google Scholar 

  16. Latronico N, Bolton CF (2011) Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neural 10:931–941

    Article  Google Scholar 

  17. Latronico N, Shehu I, Guarneri B (2009) Use of electrophysiologictes ting. Crit Care Med 37:S316–320

    Article  Google Scholar 

  18. Lefaucheur JP, NordineT, Rodriguez P, Brochard L (2006) Origin of ICU acquired paresis determined by direct muscle Stimulation. J Neural Neurosurg Psychiatry 77:500–506

    Article  Google Scholar 

  19. Novak KR, Nardelli P, CopeTC et al (2009) Inactivation of sodium Channels underlies reversible neuropathy during critical illness in rats. J Clin In vest 119:11501–158

    Google Scholar 

  20. Rochester CL (2009) Rehabilitation in the intensive care unit. Semin Respir Crit Care Med 30:656–669

    Article  PubMed  Google Scholar 

  21. SchaafM van der, Beelen A, VosR de (2004) Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil 26:11891–197

    Google Scholar 

  22. Rieh MM, Bird SJ, Raps EC et al (1997) Direct muscle Stimulation in acute quadriplegic myopathy. Muscle Nerve 20:665–673

    Google Scholar 

  23. Stevens RD, Dowdy DW, Michaels RK etal (2007) Neuromusculardysfunc tion acquired in critical illness: a sys tematic review. Intensive Care Med 33:1876–1891

    Article  PubMed  Google Scholar 

  24. TennilaA, SalmiT, PettilaVetal (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response Syndrome or sepsis. Intensive Care Med 26:1360–1363

    Google Scholar 

  25. Trojaborg W (2006) Electrophysio logic techniques in critical illness associated weakness. J Neural Sei 242:83–85

    Google Scholar 

  26. WeberCarstens S, Deja M, Koch S et al (2010) Risk factors in critical illness myopathy during the early course of critical illness: a prospective observa tional study. Crit Care 14:R119

    Article  Google Scholar 

  27. WeberCarstens S, Koch S, Spuler S et al (2009) Nonexcitable muscle membrane predicts intensive care unitac quired paresis in mechanically ven tilated, sedated patients. Crit Care Med 37:2632–2637

    Google Scholar 

  28. Wehler M (2011) Langzeitprognose alter Patienten nach intensivmedizinischer Behandlung. Med Klin Inten sivmed Notfmed 106:29–33

    Google Scholar 

  29. Wieske L, Harmsen RE, Schultz MJ et al (2011) Is critical illness neuromyo pathy and duration of mechanical Ventilation decreased by strict glucose control? Neurocrit Care 14:475–481

    Article  PubMed  Google Scholar 

  30. Witt NJ, Zochodne DW, Bolton CF et al (1991) Peripheral nerve funetion in sepsis and multiple organ failure. Chest 99:176–184

    Article  PubMed  Google Scholar 

  31. ZinkW, Kollmar R, SchwabS (2009) Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neural 5:372–379

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Grimm, A., Günther, A., Witte, O., Axer, H. (2013). Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie. In: Janssens, U., Joannidis, M., Mayer, A. (eds) Weiterbildung Intensivmedizin und Notfallmedizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40738-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-40738-3_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-40737-6

  • Online ISBN: 978-3-642-40738-3

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics